Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 83 publications.

Stirnadel-Farrant HA, Xu X, Kwiatek J, Jain P, Meyers J, Candrilli S, Mines D, Datto CJ. Characteristics, treatment patterns, healthcare resource utilization and costs in patients with bullous pemphigoid: a retrospective analysis of US health insurance claims data. J Am Acad Dermatol. 2023 Dec;13:117-25. doi: 10.1016/j.jdin.2023.04.014

Stirnadel-Farrant HA, Xu X, Kwiatek J, Jain P, Meyers J, Candrilli S, Mines D, Datto CJ. Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: a retrospective analysis of US health insurance claims data. JAAD Int. 2023 Jun 9;13:117-25. doi: 10.1016/j.jdin.2023.04.014

Rebordosa C, Farkas DK, Montonen J, Laugesen K, Voss F, Aguado J, Bothner U, Rothman KJ, Zint K, Mines DI, Ehrenstein V. Cardiovascular events and all-cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long-acting beta2-agonists. Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):827-39. doi: 10.1002/pds.5432

Xu X, Datto C, Kwiatek J, Meyers J, Candrilli S, Mines D, Stirnadel-Farrant H. Comparison of healthcare resource utilization and costs in patients with and without Bullous Pemphigoid: a retrospective analysis of US health insurance claims data. Poster presented at the ISPOR 2022 Conference; May 18, 2022. Washington, DC. [abstract] Value Health. 2022 Jun; 25(6 S1).

Ersbøll AK, Sengupta K, Pukkala E, Bolin K, Aas E, Emneus M, Ramey DR, Brady JE, Mines D, Aasbjerg K, Vestergaard C, Gislason G, Born AP, Kjærulff TM. Desloratadine exposure and incidence of seizure: a nordic post-authorization safety study using a new-user cohort study design, 2001-2015. Drug Saf. 2021 Nov;44(11):1231-42. doi: 10.1007/s40264-021-01106-7

Kjær Ersboll A, Majlund Kjærulff T, Sengupta K, Pukkala E, Bolin K, Emneus M, Rosen Ramey D, Brady JE, Mines D, Aasbjerg K, Vestergaard C, Gislason G. Association between desloratadine use and incidence of cardiac outcomes: a Nordic cohort study, 2001-2015. Presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Kjær Ersboll A, Majlund Kjærulff T, Sengupta K, Pukkala E, Bolin K, Emneus M, Mines D, Rosen Ramey D, Brady JE, Aasbjerg K, Vestergaard C, Gislason G. Association between desloratadine use and incidence of non-febrile seizure: a Nordic cohort study, 2001-2015. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Nguyen AM, Muccino D, Birring S, Bacci ED, Vernon MK, Mines D, Smith JA. Defining minimal clinically important differences (MCID) in chronic cough: analyses of objective cough counts from a phase 2 randomized controlled trial. Poster presented at the 2019 Annual Meeting of the American Academy of Asthma, Allergy and Immunology; February 2019. [abstract] J Allergy Clin Immunol. 2019 Feb; 143(2 Supplement):AB169. doi: 10.1016/j.jaci.2018.12.519

Mines D, Bacci ED, Nguyen AM, Shaffer S, Smith JA, Vernon M. Assessment of inter- and intra-rater reliability of objective cough frequency in patients with chronic cough. Poster presented at the 2019 European Respiratory Society (ERS) International Congress; October 2019. Madrid, Spain. [abstract] Eur Respir J. 2019; 54(Suppl 63):PA4342. doi: 10.1183/13993003.congress-2019.PA4342

Wang FT, Green E, Mines D, Mehta V, Lin ND. A study to assess the capture of sublingual immunotherapy within an electronic health record (EHR) system. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2018. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 25(S3):395-6.

Wang T, Liu Z, Mines D. Adding of CPT codes improves classification of type of bowel resection based only on ICD-9-CM procedure codes. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2018. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 25(S3):162.

Fortuny J, Rasouliyan L, Mines D, Tormos A, Earley E, Perez-Gutthann S, Domenech E, Gisbert JP. Characterization of patients with ulcerative colitis in a post-authorization safety study of golimumab based in the Spanish ENEIDA Registry. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):47. doi: 10.1002/pds.4629

Warren DK, Nickel KB, Wallace AE, Mines D, Tian F, Symons WJ, Fraser VJ, Olsen MA. Risk factors for surgical site infection after cholecystectomy. Open Forum Infect Dis. 2017 Feb 22;4(2):ofx036. doi: 10.1093/ofid/ofx036

Nickel KB, Wallace AE, Warren DK, Ball KE, Mines D, Fraser VJ, Olsen MA. Modification of claims-based measures improves identification of comorbidities in non-elderly women undergoing mastectomy for breast cancer: a retrospective cohort study. BMC Health Serv Res. 2016 Aug 16;16(a):388. doi: 10.1186/s12913-016-1636-7

Olsen MA, Nickel KB, Margenthaler JA, Fox IK, Ball KE, Mines D, Wallace AE, Colditz GA, Fraser VJ. Development of a risk prediction model to individualize risk factors for surgical site infection after mastectomy. Ann Surg Oncol. 2016 Aug;23(8):2471-9. doi: 10.1245/s10434-015-5083-1

Olsen MA, Nickel KB, Fox IK, Margenthaler JA, Ball KE, Mines D, Wallace AE, Fraser VJ. Incidence of surgical site infection following mastectomy with and without immediate reconstruction using private insurer claims data. Infect Control Hosp Epidemiol. 2015 Aug;36(8):907-14. doi: 10.1017/ice.2015.108

Olsen MA, Nickel KB, Margenthaler JA, Wallace AE, Mines D, Miller JP, Fraser VJ, Warren DK. Increased risk of surgical site infection among breast-conserving surgery re-excisions. Ann Surg Oncol. 2015 Jun;22(6):2003-9. doi: 10.1245/s10434-014-4200-x

Tennis P, Chan KA, Curkendall SN, Li DK, Mines D, Peterson C, Andrews EB, Calingaert B, Chen HY, Deshpande G, Everage N, Holick CN, Meyer NM, Nkhoma ET, Quinn S, Rothman KJ, Esposito DB. Topiramate use during pregnancy and major congenital malformations in multiple populations. Birth Defects Res Part A Clin Mol Teratol. 2015 Apr;103(4):269-75. doi: 10.1002/bdra.23357.

Olsen MA, Nickel KB, Wallace AE, Mines D, Fraser VJ, Warren DK. Stratification of surgical site infection by operative factors and comparison of infection rates after hernia repair. Infect Control Hosp Epidemiol. 2015 Mar;36(3):329-35. doi: 10.1017/ice.2014.44

Quinlan SC, Hawes JCL, Mines D, Ahmed S, Lanes S, Mehta V, Holick CN, Santanello N, Mast TC. Performance of an administrative claims algorithm to estimate the incidence of pure red cell aplasia in chronic hepatitis C patients. Epidemiology reports. 2015;3(1). doi: 10.7243/2054-9911-3-1

Mandl KD, Olson KL, Mines D, Liu C, Tian F. Provider collaboration: cohesion, constellations, and shared patients. J Gen Intern Med. 2014 Nov;29(11):1499-505. doi: 10.1007/s11606-014-2964-0

Mines D, Tennis P, Curkendall SM, Li DK, Peterson C, Andrews EB, Calingaert B, Chen H, Deshpande G, Esposito DB, Everage N, Holick CN, Meyer NM, Nkhoma ET, Quinn S, Rothman KJ, Chan KA. Topiramate use in pregnancy and the birth prevalence of oral clefts. Pharmacoepidemiol Drug Saf. 2014 Oct 1;23(10):1017-25. doi: 10.1002/pds.3612

Warren DK, Nickel KB, Wallace AE, Mines D, Fraser VJ, Olsen MA. Can additional information be obtained from claims data to support surgical site infection diagnosis codes? Infect Control Hosp Epidemiol. 2014 Oct;35(S3):S124-32. doi: 10.1086/677830

Warren DK, Nickel KB, Wallace AE, Mines D, Frazer VJ, Olsen MA. Validation of claims data to identify surgical site infections with antibiotic utilization data. Poster presented at the 30th ICPE International Conference on Pharmacoepidemiology and Therapeutic Risk Management; October 2014. Taipei, Taiwan. [abstract] Pharmacoepidemiol Drug Saf. 2014 Sep 30; 23(S1).

Mines D. Embracing pharmacoepidemiology to ensure effectiveness in the design and implementation of an evolving pharmacovigilance practice. Presented at the 2014 4th Annual Pharmacovigilance, Risk Management and AER conference; September 17, 2014.

Nickel KB, Warren DK, Wallace AE, Mines D, Fraser VJ, Olsen MA. Can administrative data accurately identify comorbidities in non-elderly populations? Poster presented at the 2014 47th Annual Meeting of the Society for Epidemiologic Research; June 2014. Seattle, WA.

Nickel KB, Wallace AE, Warren DK, Mines D, Olsen MA. Using claims data to perform surveillance for surgical site infection: the devil is in the details. Advances in the prevention and control of health care-associated infections. Agency for Healthcare Research and Quality (US) publication No. 14-0003. 2014. Rockville: Agency for Healthcare Research and Quality.

Mines D. Large databases used in pharmacoepidemiology research. Presented at the 2014 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting; March 19, 2014. Atlanta, GA.

Esposito D, Lanes S, Deshpande G, Holick CN, Mines D, O’Quinn S, Trung N. Identification and confirmation of IPF cases in an electronic insurance claims database. Poster presented at the 2013 OMOP-IMEDS Symposium; November 2013. Bethesda, MD.

Wahl PW, Rassen JA, Rosenman MB, Mines D, Glynn RJ, Schneeweiss S. Information gained by linking administrative claims to structured electronic health record data in a statin comparative effectiveness study. Presented at the 2013 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct; 22(Suppl 1):30. doi: 10.1002/pds.3512

Esposito DB, Lensen L, Eisenberg DF, Grant A, Hawes JCL, Holick CN, Ke X, Luthra R, Maloney J, Mehta V, Mines D. Background rates of anaphylaxis in general and allergic populations. Poster presented at the 2013 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal, Quebec. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct; 22(Suppl 1):397.

Jafarzadeh R, Warren DK, Nickel KB, Wallace AE, Mines D, Frazer VJ, Olsen MA. Bayesian estimation of the accuracy of ICD-9-CM- and CPT-4-based algorithms to identify cholecystectomy procedures in administrative data without a reference standard. Poster presented at the 2013 American College of Epidemiology (ACE) Conference; September 2013. Louisville, KY.

Everage NJ, Esposito DB, Li Z, Deshpande G, Holick CN, Chan KA, Mines D. Positive predictive values of algorithms for ascertainment of major congenital malformations in administrative databases. Presented at the 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Aug; 22(Suppl 1):194.

He J, Leonard CE, Rosenman MB, Mines D, Reich C. Advanced topics on database algorithm development and validation. Presented at the 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal, Canada.

Patorno E, Glynn RJ, Hernandez-Diaz S, Avorn J, Wahl PM, Bohn RL, Mines D, Liu J, Schneeweiss S. Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings. J Am Heart Assoc. 2013 Jul 30;2(4):e000208. doi: 10.1161/JAHA.113.000208.

Mines D, Nickel KB, Wallace AE, Warren DK, Olsen MA. Using claims data for surgical site infection surveillance after herniorrhaphy. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):a79.

Esposito DB, Zhao Y, Fusco G, Holick CN, Nkhoma E, Marcinak J, Shah T, Joseph G, Mines D. Risk of drug-induced liver injury in a commercially-insured population of patients with type 2 diabetes mellitus. Poster presented at the 2012 Annual Meeting of the American College of Gastroenterology; October 2012. Las Vegas, NV.

Nordstrom BL, Mines D, Gu Y, Mercaldi C, Aquino P, Harrison MJ. Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents. Arthritis Care Res (Hoboken). 2012 Sep;64(9):1357-64. doi: 10.1002/acr.21709

Mines D, Tennis PS, Curkendall S, Li A, Peterson C, Andrews EB, Calingaert B, Rothman KJ. Topiramate use in pregnancy and risk of oral clefts. Presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):320. doi: 10.1111/j.1399-5448.2012.03324.x

Rowan CG, Brunelli SM, Munson J, Flory J, Reese PP, Hennessy S, Lewis J, Mines D, Barrett JS, Bilker W, Strom BL. Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network. Pharmacoepidemiol Drug Saf. 2012 May;21(5):494-506. doi: 10.1002/pds.3199

Nkohma E, Zhao Y, Esposito D, Mines D, Holick C. Patterns of medication use during pregnancy and prevalence of birth defects in a large administrative claims database. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012; 21(Suppl 3):390.

Mines D, Gu Y, Kou TD, Cooper GS. Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):111-8. doi: 10.1002/pds.2057

Mines D. Invited editorial. Commentary on the validation studies of sudden cardiac death and ventricular arrhythmia by Hennessy et al. and Chung et al. Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):573-5. doi: 10.1002/pds.1913.

Harrison M, Cummins C, Horneff G, Southwood T, Mines D. Cancer risk in juvenile arthritis patients exposed to etanercept: results from three observational cohorts. Presented at the 2010 Annual European Congress of Rheumatology; June 2010. Rome, Italy.

Martinez C, Assimes TL, Mines D, Dell'aniello S, Suissa S. Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ. 2010 Feb 5;340:c249. doi: 10.1136/bmj.c249

Mines D. Methodological challenges of assessing the association of antidepressant use and suicide risk using automated data. Presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI.

Bongartz T, Warren FC, Mines D, Matteson EL, Abrams KR, Sutton AJ. Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials. Ann Rheum Dis. 2009 Jul;68(7):1177-83. doi: 10.1136/ard.2008.094904

Geier J, Juhaeri J, Mines D, Mosholder A, Trivedi M, Eng S, Skovron ML, Stang P, Volkova N. Assessing the association of pharmacotherapeutics and suicidal behavior: lessons from the front. Presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009; 18(S1):S125.

Bongartz T, Warren FC, Mines D, Matteson EL, Abrams KR, Sutton AJ. Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials. Presented at the 2008 Annual Meeting of the American College of Rheumatology; October 2008. San Francisco, CA. [abstract] Arthritis Rheum. 2008 Sep; 58(9 Suppl):S782.

Cooper G, Mines D, Gu Y. Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Presented at the 24th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(S1):S110-1.